Featured Articles
Latest Articles
Coronary artery bypass grafting: Practice trends and projectionsFuture directions include expanding the use of multiarterial grafting, offering patients less-invasive approaches, and enhancing operative recovery.
- Can my patient with a ‘sulfa allergy’ receive celecoxib or other nonantimicrobial sulfonamides?
There is no cross-reactivity between antimicrobial and nonantimicrobial sulfonamides, and patients with a history of immunoglobulin E–mediated reaction to a sulfonamide antibiotic can receive nonantimicrobial sulfonamides.
- Cardiovascular disease in people living with HIV: Risk assessment and management
Because people living with HIV develop coronary artery disease much earlier than the general population, careful attention must be given to assessment and management of their cardiovascular risk.
- Heart to heart: Progress in cardiovascular disease prevention for people living with HIV
The already higher cardiovascular risk in people living with HIV is exacerbated by social determinants of health such as socioeconomic status, access to healthcare, and systemic discrimination. Interventions that address this risk must be based in medical science and equity.
- Hyperglycemic crises in adults: A look at the 2024 consensus report
A new report introduces revised criteria for the diagnosis of diabetic ketoacidosis and hyperglycemic hyperosmolar state, as well as new recommendations for assessment, management, and prevention of these disorders.
- All sulfa drugs are not created equal
Misinformation about “sulfa allergy” can result in unnecessary avoidance of useful medications and the prescription of less effective alternatives.
Cleveland Clinic Journal of Medicine, published by Cleveland Clinic, provides busy clinicians with practical information to promote better patient care.